The elusive P2X7 macropore
F Di Virgilio, G Schmalzing, F Markwardt - Trends in cell biology, 2018 - cell.com
ATP, which is released under pathological conditions and is considered a damage-
associated molecular pattern (DAMP), activates P2X7 receptors (P2X7Rs), trimeric plasma …
associated molecular pattern (DAMP), activates P2X7 receptors (P2X7Rs), trimeric plasma …
P2X7 receptor: an emerging target in central nervous system diseases
B Sperlágh, P Illes - Trends in pharmacological sciences, 2014 - cell.com
The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a
potential drug target because of its widespread involvement in inflammatory diseases as a …
potential drug target because of its widespread involvement in inflammatory diseases as a …
The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
The P2X7 receptor forms a dye-permeable pore independent of its intracellular domain but dependent on membrane lipid composition
A Karasawa, K Michalski, P Mikhelzon, T Kawate - Elife, 2017 - elifesciences.org
The P2X7 receptor mediates extracellular ATP signaling implicated in the development of
devastating diseases such as chronic pain and cancer. Activation of the P2X7 receptor leads …
devastating diseases such as chronic pain and cancer. Activation of the P2X7 receptor leads …
Inhibition of the P2X7–PANX1 complex suppresses spreading depolarization and neuroinflammation
SP Chen, T Qin, JL Seidel, Y Zheng, M Eikermann… - Brain, 2017 - academic.oup.com
Spreading depolarization is a wave of neuronal and glial depolarization. Within minutes
after spreading depolarization, the neuronal hemichannel pannexin 1 (PANX1) opens and …
after spreading depolarization, the neuronal hemichannel pannexin 1 (PANX1) opens and …
P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases
P2X7 receptor, a purinergic receptor family member, is abundantly expressed on many cells,
including immune, muscle, bone, neuron, and glia. It acts as an ATP-activated cation …
including immune, muscle, bone, neuron, and glia. It acts as an ATP-activated cation …
The key role of astrocytes in amyotrophic lateral sclerosis and their commitment to glutamate excitotoxicity
F Provenzano, C Torazza, T Bonifacino… - International Journal of …, 2023 - mdpi.com
In the last two decades, there has been increasing evidence supporting non-neuronal cells
as active contributors to neurodegenerative disorders. Among glial cells, astrocytes play a …
as active contributors to neurodegenerative disorders. Among glial cells, astrocytes play a …
P2X7 receptor and purinergic signaling: orchestrating mitochondrial dysfunction in neurodegenerative diseases
AS Zelentsova, AV Deykin, VO Soldatov, AA Ulezko… - Eneuro, 2022 - eneuro.org
Mitochondrial dysfunction is one of the basic hallmarks of cellular pathology in
neurodegenerative diseases. Since the metabolic activity of neurons is highly dependent on …
neurodegenerative diseases. Since the metabolic activity of neurons is highly dependent on …
Nociceptive transmission and modulation via P2X receptors in central pain syndrome
YH Kuan, BC Shyu - Molecular brain, 2016 - Springer
Painful sensations are some of the most frequent complaints of patients who are admitted to
local medical clinics. Persistent pain varies according to its causes, often resulting from local …
local medical clinics. Persistent pain varies according to its causes, often resulting from local …
Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1
LDC Mannelli, M Marcoli, L Micheli, M Zanardelli… - …, 2015 - Elsevier
Anticancer therapy based on the repeated administration of oxaliplatin is limited by the
development of a neuropathic syndrome difficult to treat. Oxaliplatin neurotoxicity is based …
development of a neuropathic syndrome difficult to treat. Oxaliplatin neurotoxicity is based …